Results 221 to 230 of about 33,850 (239)

The evaluation of follow-up strategies of watch-and-wait patients with a complete response after neoadjuvant therapy in rectal cancer

Colorectal Disease, 2021
Aim: Many of the current follow-up schedules in a watch-and-wait approach include very frequent MRI and endoscopy examinations to ensure early detection of local regrowth (LR).
Jurriaan B Tuynman, Monique Maas, Jarno Melenhorst   +2 more
exaly   +1 more source

Patient perspectives of ‘Watch and Wait’ for chronic haematological cancers: Findings from a qualitative study [PDF]

European Journal of Oncology Nursing, 2023
PURPOSE: Chronic blood cancers are incurable, and characterised by unpredictable, remitting-relapsing pathways. Management often involves periods of observation prior to treatment (if required), and post-treatment, in an approach known as 'Watch and Wait'
Dorothy McCaughan, Eve Roman, Alexandra Smith   +2 more
exaly   +2 more sources

Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer [PDF]

Current Colorectal Cancer Reports, 2018
Purpose of Review Pathological complete response is seen in approximately one fifth of rectal cancer patients following neoadjuvant chemoradiation. Since these patients have excellent oncological outcomes, there has been a rapidly growing interest in ...
Gina Brown, Svetlana Balyasnikova
exaly   +2 more sources

Psychological Burden in Meningioma Patients under a Wait-and-Watch Strategy and after Complete Resection Is High—Results of a Prospective Single Center Study

Cancers, 2020
The diagnosis of intracranial meningiomas as incidental findings is increasing by growing availability of MRI diagnostics. However, the psychological distress of patients with incidental meningiomas under a wait-and-watch strategy is unknown.
Darius Kalasauskas, Naureen Keric, Mirjam Renovanz   +2 more
exaly   +2 more sources

Nationwide analysis on the role of neoadjuvant radiotherapy and watch and wait in rectal cancer [PDF]

European Journal of Surgical Oncology
Introduction: Patients receiving neoadjuvant short-course radiotherapy (SCRT) or chemoradiotherapy (CRT) for primary non-metastasized rectal cancer may achieve a clinical complete response and can be surveilled following the watch and wait strategy.
Cornelis Verhoef, Pim B Olthof, Denise Hilling   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Oncologic outcomes of watch-and-wait strategy or surgery for low to intermediate rectal cancer in clinical complete remission after adjuvant chemotherapy: a systematic review and meta-analysis

International Journal of Colorectal Disease, 2023
Yaping Cui
exaly  

Watch-and-wait strategy in rectal cancer: Is there a tumour size limit? Results from two pooled prospective studies

Radiotherapy and Oncology, 2021
Wojciech Polkowski, Krzysztof Bujko, Michal Jankowski   +2 more
exaly  

Watch and Wait in Rectal Cancer After a Complete Response to Chemoradiotherapy – Is It Safe and Are We Doing Enough?

Clinical Oncology, 2023
Simon Powell, James Wyatt
exaly  

The Cost-effectiveness of Watch and Wait for Rectal Cancer

Clinical Oncology, 2023
Christopher Rao
exaly  

The ‘inbetweeners’: living on a watch and wait approach for chronic lymphocytic leukaemia – a qualitative study

British Journal of Nursing, 2023
Maura Dowling, Martina Giltenane
exaly